Literature DB >> 20624949

Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model.

Ayumi Yoshizaki1, Koichi Yanaba, Yohei Iwata, Kazuhiro Komura, Asako Ogawa, Yuichiro Akiyama, Eiji Muroi, Toshihide Hara, Fumihide Ogawa, Motoi Takenaka, Kazuhiro Shimizu, Minoru Hasegawa, Manabu Fujimoto, Thomas F Tedder, Shinichi Sato.   

Abstract

Mice s.c. injected with bleomycin, an experimental model for human systemic sclerosis, develop skin and lung fibrosis, which is mediated by inflammatory cell infiltration. This process is highly regulated by multiple adhesion molecules and does not require Ag sensitization. To assess the role of adhesion molecules in this pathogenetic process, bleomycin-induced fibrosis was examined in mice lacking adhesion molecules. L-selectin and/or ICAM-1 deficiency inhibited skin and lung fibrosis with decreased Th2 and Th17 cytokines and increased Th1 cytokines. In contrast, P-selectin deficiency, E-selectin deficiency with or without P-selectin blockade, or P-selectin glycoprotein ligand 1 (PSGL-1) deficiency augmented the fibrosis in parallel with increased Th2 and Th17 cytokines and decreased Th1 cytokines. Furthermore, loss of L-selectin and/or ICAM-1 reduced Th2 and Th17 cell numbers in bronchoalveolar lavage fluid, whereas loss of P-selectin, E-selectin, or PSGL-1 reduced Th1 cell numbers. Moreover, Th1 cells exhibited higher PSGL-1 expression and lower expression of LFA-1, a ligand for ICAM-1, whereas Th2 and Th17 cells showed higher LFA-1 and lower PSGL-1 expression. This study suggests that L-selectin and ICAM-1 regulate Th2 and Th17 cell accumulation into the skin and lung, leading to the development of fibrosis, and that P-selectin, E-selectin, and PSGL-1 regulate Th1 cell infiltration, resulting in the inhibition of fibrosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20624949      PMCID: PMC3733122          DOI: 10.4049/jimmunol.0901778

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  61 in total

1.  Circulating gamma/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization.

Authors:  R Giacomelli; P Cipriani; A Fulminis; G Barattelli; M Matucci-Cerinic; S D'Alò; G Cifone; G Tonietti
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

2.  ICAM-1 mediates lung leukocyte recruitment but not pulmonary fibrosis in a murine model of bleomycin-induced lung injury.

Authors:  T Matsuse; S Teramoto; H Katayama; E Sudo; H Ekimoto; H Mitsuhashi; Y Uejima; Y Fukuchi; Y Ouchi
Journal:  Eur Respir J       Date:  1999-01       Impact factor: 16.671

3.  Intercellular adhesion molecule-1 and L-selectin regulate bleomycin-induced lung fibrosis.

Authors:  Yasuhito Hamaguchi; Yoriko Nishizawa; Masahide Yasui; Minoru Hasegawa; Yuko Kaburagi; Kazuhiro Komura; Tetsuya Nagaoka; Eriko Saito; Yuka Shimada; Kazuhiko Takehara; Takafumi Kadono; Douglas A Steeber; Thomas F Tedder; Shinichi Sato
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

4.  L-selectin or ICAM-1 deficiency reduces an immediate-type hypersensitivity response by preventing mast cell recruitment in repeated elicitation of contact hypersensitivity.

Authors:  Yuka Shimada; Minoru Hasegawa; Yuko Kaburagi; Yasuhito Hamaguchi; Kazuhiro Komura; Eriko Saito; Kazuhiko Takehara; Douglas A Steeber; Thomas F Tedder; Shinichi Sato
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

Review 5.  Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease.

Authors:  A Rosen; L Casciola-Rosen
Journal:  Cell Death Differ       Date:  1999-01       Impact factor: 15.828

6.  Relative contributions of selectins and intercellular adhesion molecule-1 to tissue injury induced by immune complex deposition.

Authors:  Koichi Yanaba; Yuko Kaburagi; Kazuhiko Takehara; Douglas A Steeber; Thomas F Tedder; Shinichi Sato
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

7.  Treatment with alpha-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis.

Authors:  Toru Kimura; Yukio Ishii; Yuko Morishima; Akira Shibuya; Kazuko Shibuya; Masaru Taniguchi; Mie Mochizuki; Ahmed E Hegab; Tohru Sakamoto; Akihiro Nomura; Kiyohisa Sekizawa
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

8.  Resident cell chemokine expression serves as the major mechanism for leukocyte recruitment during local inflammation.

Authors:  Eva García-Ramallo; Teresa Marques; Neus Prats; Jordi Beleta; Steven L Kunkel; Nuria Godessart
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

9.  Inhibition of TCR-mediated shedding of L-selectin (CD62L) on human and mouse CD4+ T cells by metalloproteinase inhibition: analysis of the regulation of Th1/Th2 function.

Authors:  Nigel D L Savage; Stephen H Harris; Adriano G Rossi; Bernadette De Silva; Sarah E M Howie; Guy T Layton; Jonathan R Lamb
Journal:  Eur J Immunol       Date:  2002-10       Impact factor: 5.532

10.  Possible role of apoptosis in the pathogenesis of bleomycin-induced scleroderma.

Authors:  Toshiyuki Yamamoto; Kiyoshi Nishioka
Journal:  J Invest Dermatol       Date:  2004-01       Impact factor: 8.551

View more
  49 in total

1.  P-selectin glycoprotein ligand-1 is needed for sequential recruitment of T-helper 1 (Th1) and local generation of Th17 T cells in dextran sodium sulfate (DSS) colitis.

Authors:  Jeffrey B Brown; Paul Cheresh; Zheng Zhang; Hyunji Ryu; Elizabeth Managlia; Terrence A Barrett
Journal:  Inflamm Bowel Dis       Date:  2012-02       Impact factor: 5.325

Review 2.  Vasculopathy in scleroderma.

Authors:  Yoshihide Asano; Shinichi Sato
Journal:  Semin Immunopathol       Date:  2015-07-08       Impact factor: 9.623

3.  Early systemic sclerosis: serum profiling of factors involved in endothelial, T-cell, and fibroblast interplay is marked by elevated interleukin-33 levels.

Authors:  Serena Vettori; Giovanna Cuomo; Michele Iudici; Virginia D'Abrosca; Veronica Giacco; Giusi Barra; Raffaele De Palma; Gabriele Valentini
Journal:  J Clin Immunol       Date:  2014-04-24       Impact factor: 8.317

Review 4.  Interleukin-17: Friend or foe in organ fibrosis.

Authors:  Kritika Ramani; Partha S Biswas
Journal:  Cytokine       Date:  2019-02-14       Impact factor: 3.861

5.  Difference in Th1 and Th17 lymphocyte adhesion to endothelium.

Authors:  Pilar Alcaide; Elena Maganto-Garcia; Gail Newton; Richard Travers; Kevin J Croce; De-xiu Bu; Francis W Luscinskas; Andrew H Lichtman
Journal:  J Immunol       Date:  2012-01-04       Impact factor: 5.422

6.  MyD88 provides a protective role in long-term radiation-induced lung injury.

Authors:  Willie J Brickey; Isabel P Neuringer; William Walton; Xiaoyang Hua; Ellis Y Wang; Sushmita Jha; Gregory D Sempowski; Xuebin Yang; Suzanne L Kirby; Stephen L Tilley; Jenny P-Y Ting
Journal:  Int J Radiat Biol       Date:  2012-02-06       Impact factor: 2.694

7.  Interleukin-17A is involved in development of spontaneous pulmonary emphysema caused by Toll-like receptor 4 mutation.

Authors:  Qing-qing Wang; Hong-zhen Yang; Han-zhi Liu; Su Mi; Xiao-wei Zhang; Hui-min Yan; Yong-gang Ma; Xiao-xing Wang; Zhuo-wei Hu
Journal:  Acta Pharmacol Sin       Date:  2011-06-27       Impact factor: 6.150

Review 8.  Endoplasmic reticulum stress in the pathogenesis of fibrotic disease.

Authors:  Jonathan A Kropski; Timothy S Blackwell
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

Review 9.  Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.

Authors:  Kelli P A MacDonald; Geoffrey R Hill; Bruce R Blazar
Journal:  Blood       Date:  2016-11-07       Impact factor: 22.113

10.  Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis.

Authors:  Ryosuke Saigusa; Yoshihide Asano; Takashi Taniguchi; Takashi Yamashita; Yohei Ichimura; Takehiro Takahashi; Tetsuo Toyama; Ayumi Yoshizaki; Koji Sugawara; Daisuke Tsuruta; Tadatsugu Taniguchi; Shinichi Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.